Renalytix plc Deferred Tax Assets, Net of Valuation Allowance
Renalytix plc (RNLXY) had Deferred Tax Assets, Net of Valuation Allowance of $82.00 thousand as of 2024-06-30, per its 10-K filed 2024-09-30.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance
us-gaap:DeferredTaxAssetsNet · last filed 2024-09-30
- 2024-06-30: Deferred Tax Assets, Net of Valuation Allowance $82.00K.
- 2023-06-30: Deferred Tax Assets, Net of Valuation Allowance $453.00K.
- 2022-06-30: Deferred Tax Assets, Net of Valuation Allowance $578.00K.
- 2021-06-30: Deferred Tax Assets, Net of Valuation Allowance $2.08M.
| Period end | Deferred Tax Assets, Net of Valuation Allowance |
|---|---|
| 2024-06-30 | $82.00K 10-K · filed 2024-09-30 |
| 2023-06-30 | $453.00K 10-K · filed 2024-09-30 |
| 2022-06-30 | $578.00K 10-K · filed 2023-09-28 |
| 2021-06-30 | $2.08M 20-F · filed 2022-10-31 |
| 2020-06-30 | $131.00K 20-F · filed 2022-10-31 |
| 2019-06-30 | $58.00K 20-F/A · filed 2022-08-01 |
| 2018-06-30 | $0.00 20-F/A · filed 2020-11-10 |